Corvus Pharmaceuticals to present at Guggenheim Healthcare Innovation Conference.
ByAinvest
Friday, Oct 31, 2025 7:35 am ET1min read
CRVS--
Corvus Pharmaceuticals announced that its leadership team will participate in a fireside chat and one-on-one meetings at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, MA. The event is scheduled for November 10, 2025, and a webcast will be available on the company's website for 90 days following the event. Corvus is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer and immune diseases, with its lead product candidate being soquelitinib, an investigational drug that selectively inhibits the protein ITK.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet